Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Working Capital/Sales

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023
   Working Capital/Sales(x) 1.930.791.51

What is the latest Working Capital/Sales ratio of GENPHARMASEC ?

The latest Working Capital/Sales ratio of GENPHARMASEC is 1.93 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.93
Mar20240.79
Mar20231.51

How is Working Capital/Sales of GENPHARMASEC Trending?

Years Working Capital/Sales % Change
Mar2025 1.93
144.30
Mar2024 0.79
-47.68
Mar2023 1.51 -

Other Financial Ratios of GENPHARMASEC


Compare Working Capital/Sales ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.8 Cr 1.7% 8.3% -40.3% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹6,405.3 Cr 7.2% 2.5% -20% Stock Analytics
KIRI INDUSTRIES ₹2,434.8 Cr 7.6% 5.2% -36.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,633.2 Cr 7% 8.5% -29% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,093.3 Cr 3.7% 12.9% 33.6% Stock Analytics
BODAL CHEMICALS ₹815.5 Cr 7.3% 47.2% -2.1% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1.7%

8.3%

-40.3%

SENSEX

5.8%

-1.7%

1.2%


You may also like the below Video Courses